Clough Capital Partners’s Surgery Partners SGRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-92,746
Closed -$2.97M 178
2023
Q4
$2.97M Sell
92,746
-45,157
-33% -$1.31M 0.33% 69
2023
Q3
$4.03M Sell
137,903
-63,900
-32% -$2.3M 0.43% 64
2023
Q2
$9.08M Buy
201,803
+52,100
+35% +$1.99M 0.91% 39
2023
Q1
$5.16M Sell
149,703
-138,210
-48% -$4.49M 0.56% 64
2022
Q4
$8.02M Sell
287,913
-78,535
-21% -$2.08M 0.81% 43
2022
Q3
$8.57M Buy
366,448
+142,567
+64% +$4.55M 0.91% 26
2022
Q2
$6.47M Sell
223,881
-74,900
-25% -$3.27M 0.8% 36
2022
Q1
$16.4M Buy
+298,781
New +$14.8M 1.25% 32

Other funds holding SGRY

Clough Capital Partners's SGRY Position: Q1 2024 in Review

Clough Capital Partners sold out of Surgery Partners (SGRY) in Q1 2024, closing a stake of 92,746 shares — an estimated $2.97M sold.

Clough Capital Partners first reported a position in SGRY in Q1 2022 and held it in 8 quarters. The position peaked at $16.4M in Q1 2022. 180 funds tracked by Wall St. Rank hold SGRY as of Q1 2024.

  • Clough Capital Partners reported no remaining Surgery Partners position as of Q1 2024 after selling out during the quarter.
  • Clough Capital Partners sold 92,746 Surgery Partners shares in Q1 2024, an estimated $2.97M.
  • Clough Capital Partners first reported a position in Surgery Partners in Q1 2022 and held it in 8 quarters.
  • Clough Capital Partners's Surgery Partners position peaked at $16.4M in Q1 2022.
  • 180 funds tracked by Wall St. Rank held Surgery Partners as of Q1 2024.

Based on Clough Capital Partners's 13F filing for Q1 2024, filed 15 May 2024.